Gut-liver axis: pathophysiological concepts and clinical implications
While rare, serious side effects such as pancreatitis can occur
Status of Other GLP-1 Products: As of February 21, 2025, the FDA is also monitoring other GLP-1 medications: Dulaglutide injection : Still in shortage, though the manufacturer has reported all presentations are available
These findings suggest that SPIONs inhibit the proliferation, invasion, and drug resistance of ovarian cancer stem cells, thereby reducing ovarian cancer recurrence and metastasis (Huang et al., 2020a)
Because they are not safe for everyone, proper screening via an online GLP-1evaluation is essential
DA: Data curation, Project administration, Resources, Writing review & editing